Abstract
A patient with metastatic malignant fibrous histiocytoma (MFH) achieved a complete remission with polychemotherapy lasting 42+ months. In view of this long-term survival and two similar prior reports of long-term survival after aggressive treatment, the goal of therapy for metastatic MFH must be reconsidered.
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Female
-
Histiocytoma, Benign Fibrous / drug therapy*
-
Histiocytoma, Benign Fibrous / pathology
-
Histiocytoma, Benign Fibrous / secondary
-
Humans
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / secondary
-
Middle Aged
-
Soft Tissue Neoplasms / pathology
-
Sternum / pathology